ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Activity

47 hedge funds and large institutions have $16.3M invested in Oramed Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
-5
Holders Change %
-9.62%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
4
Increased
8
Reduced
15
Closed
9
Calls
$284K
Puts
–
Net Calls
+$284K
Net Calls Change
+$262K

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$196K
2
BCM
2
BML Capital Management
Indiana
$6.94M
3
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$376K
4
Mariner
4
Mariner
Kansas
$22.7K
5
Wealth Enhancement Advisory Services
5
Wealth Enhancement Advisory Services
Minnesota
$41K

Top Sellers

1
Two Sigma Advisers
1
Two Sigma Advisers
New York
$0
2
PLC
2
Peapod Lane Capital
New York
$191K
3
Two Sigma Investments
3
Two Sigma Investments
New York
$0
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$109K
5
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$107K
Name Holding Trade Value Shares
Change 		Shares
Change %
NEWAS
51
N.E.W. Advisory Services
Wisconsin
– -$40.4K -18,900 Closed
PCM
52
Prelude Capital Management
New York
– -$28.8K -13,435 Closed
Simplex Trading
53
Simplex Trading
Illinois
– -$15K -7,244 Closed
Group One Trading
54
Group One Trading
Illinois
– -$7.08K -3,310 Closed
FHA
55
First Horizon Advisors
Tennessee
– -$3.75K -1,750 Closed
TRCT
56
Tower Research Capital (TRC)
New York
– -$1.39K -649 Closed
1 2
3